Aurobindo Pharma Income Statement
Quarterly
Yearly
The current prices are delayed, login to your account to see live prices.
LOGIN
| 2021 | 2022 | |
|---|---|---|
| EBITDA | 5,714 | 4,707 |
| EBIT | 7,473 | 3,453 |
| Earning Per Share | 91 | 45 |
| Expenses | 19,441 | 19,069 |
| Net Profit | 5,389 | 2,678 |
| Net Profit Margin | 22 | 11 |
| Operating Profit Margin | 23 | 20 |
| Profit Before Tax | 7,399 | 3,404 |
| Dividends Per Share | 4 | 9 |
| Operation Revenue | 25,155 | 23,776 |
Peer Comparison (in ₹.Cr.)
| Company | Year | EBIT | EBITDA | Net Profit | Net Worth | Profit Before Tax |
|---|---|---|---|---|---|---|
| 2023 | 0 | 0 | 8,560.84 | NA | 9,408.43 | |
| 2023 | 0 | 0 | 2,835.49 | NA | 4,038.35 | |
| 2023 | 0 | 0 | 372.90 | NA | 385.50 | |
| 2023 | 0 | 0 | 103.87 | NA | 140.39 | |
| 2022 | 1,257.60 | 2,182.90 | 978.50 | 7,628.10 | 1,190 |
The current prices are delayed, login to your account to see live prices.
LOGIN
| 2009 | 2009 | 2009 | 2009 | 2021 | |
|---|---|---|---|---|---|
| Operating Activities | 136 | 136 | 136 | 136 | 3,329 |
| Investing Activities | -406 | -406 | -406 | -406 | 599 |
| Financing Activities | 165 | 165 | 165 | 165 | -1,365 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | -105 | -105 | -105 | -105 | 2,563 |
Peer Comparison (in ₹.Cr.)
| Company | Year | Operating Activities | Investing Activities | Financing Activities | Net Cash Flow |
|---|---|---|---|---|---|
| 2023 | 4,959.33 | -7,943.68 | 2,376.07 | -608.28 | |
| 2022 | 3,325.90 | -1,871.88 | -1,599.79 | -145.77 | |
| 2023 | 723.95 | -447.59 | -261.96 | 14.40 | |
| 2020 | 140.90 | -44.50 | -38.55 | 57.85 | |
| 2017 | 640 | -498.50 | -177.50 | -36 |
Financials
All values are in Rs Cr